Product Catalog [{"id":"630","name":"Kisunla ","price":1738.13,"sku":"Kisunla (donanemab-azbt)","brand":false,"position":1,"category":"Medicines\/Neurology\/Alzheimer's disease"},{"id":"547","name":"Leqembi","price":1042.88,"sku":"Leqembi (lecanemab-irmb)","brand":"Eisai Europe Ltd","position":2,"category":"Medicines\/Neurology\/Alzheimer's disease"},{"id":"443","name":"Aduhelm","price":1334.88,"sku":"Aduhelm (aducanumab-avwa)","brand":"Biogen","position":3,"category":"Medicines\/Neurology\/Alzheimer's disease"}]
Call our support: +31 20 8084 414
Google Reviews
4.8
Toggle Nav
Search
Advanced Search
You are reading an automatically translated version of our website that may contain translation errors.
Change to English
Menu
Account

Alzheimer's disease access options

Alzheimer’s disease is a degenerative brain disorder that today affects over 40 million people around the world and is the most common cause of dementia. Believed for many years to be a normal part of aging, Alzheimer’s disease is now recognised as a condition with serious healthcare, economic, and social impacts. Researchers do not yet fully understand what causes Alzheimer’s disease, but it is believed to be caused by a combination of factors, such as aging, family history and other factors such as a link between Alzheimer's and heart disease, diabetes and obesity.
  1. Aduhelm
    Aduhelm (aducanumab-avwa)
    Alzheimer's disease
    €1,334.88
  2. Leqembi
    Leqembi (lecanemab-irmb)
    Alzheimer's disease
    €1,042.88
  3. Kisunla
    Kisunla (donanemab-azbt)
    Alzheimer's disease
    €1,738.13
View as Grid List

3 Items

Set Descending Direction
Read more about the latest treatments in Alzheimer's disease
Explore disease areas
US United States 1